These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8105590

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Rat kidney graft survival after elimination of MHC class II-positive cells by perfusion with monoclonal antibody.
    Oko A, Krzymański M, Deja A, Pawliczak E, Idasiak-Piechocka I.
    Transplant Proc; 1996 Dec; 28(6):3480-2. PubMed ID: 8962353
    [No Abstract] [Full Text] [Related]

  • 23. Blood ketone body ratio as an indicator of graft viability in rat liver allotransplantation.
    Asonuma K, Tanaka K, Uemoto S, Okamura R, Matsuoka S, Utsunomiya H, Ozawa K.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1335-7. PubMed ID: 2652441
    [No Abstract] [Full Text] [Related]

  • 24. Monoclonal antibodies against intercellular adhesion molecule 1 prolong cardiac allograft survival in cynomolgus monkeys.
    Flavin T, Ivens K, Rothlein R, Faanes R, Clayberger C, Billingham M, Starnes VA.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):533-4. PubMed ID: 1671305
    [No Abstract] [Full Text] [Related]

  • 25. The potential role of bone marrow transplantation in augmenting donor-derived immunity to hepatitis B after rat liver transplantation.
    Li J, Dahmen U, Dirsch OR, Gu Y, Polywka S, Fiedler M, Doebel L, Roggendorf M, Broelsch CE.
    Liver Transpl; 2002 Apr; 8(4):397-404. PubMed ID: 11965586
    [Abstract] [Full Text] [Related]

  • 26. The efficiency of humoral immune transfer depends on both the graft and the immunosuppressive treatment.
    Dahmen U, Li J, Gu Y, Doebel L, Fan LM, Polywka S, Dirsch O, Broelsch CE.
    Transpl Int; 2003 Mar; 16(3):161-7. PubMed ID: 12664210
    [Abstract] [Full Text] [Related]

  • 27. Effect of ex vivo perfusion with anti-Ia monoclonal antibodies on rat cardiac allograft survival.
    Sone Y, Sakagami K, Orita K.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):599-604. PubMed ID: 3547831
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Changes in prostaglandin levels in experimental liver transplantation in rats.
    Iyobe T, Izumi R, Ii T, Fukushima W, Sakamoto H, Inoue T, Muraoka K, Iwasa K, Masutani H, Hashimoto T.
    Transplant Proc; 1994 Aug; 26(4):2209-10. PubMed ID: 8066723
    [No Abstract] [Full Text] [Related]

  • 30. A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat.
    Knoop M, Cramer DV, Chapman FC, Makowka L.
    Transplant Proc; 1993 Aug; 25(4):2697-8. PubMed ID: 8356719
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Differences in cellular mechanisms in early and late immunological responses after liver transplantation in rats.
    Yamaguchi J, Ishii T, Kamohara Y, Gu W, Yamamoto T, Mizoe A, Azuma T, Fujioka H, Furui J, Kanematsu T.
    Transplant Proc; 1996 Jun; 28(3):1782-3. PubMed ID: 8658881
    [No Abstract] [Full Text] [Related]

  • 33. Effect of cyclosporine on the distribution of macrophage phenotypes in the rat hepatic allograft.
    Yamaguchi Y, Goto M, Makino Y, Takata N, Kikuchi N, Hamaguchi H, Hisama N, Otsuka Y, Mori K, Ogawa M.
    Transplant Proc; 1993 Apr; 25(2):1796-8. PubMed ID: 8470168
    [No Abstract] [Full Text] [Related]

  • 34. Spontaneous proliferation of peripheral blood mononuclear cells as an indicator for insufficient plasma levels of FK 506 in the early phase after liver transplantation.
    Kato H, Inamoto T, Kanaya S, Uyama S, Uemoto S, Tanaka K, Yamaoka Y.
    Transplant Proc; 1994 Apr; 26(2):893-5. PubMed ID: 7513481
    [No Abstract] [Full Text] [Related]

  • 35. In vivo microscopic observation of fatty liver grafts after reperfusion.
    Teramoto K, Bowers JL, Kruskal JB, Hara J, Iwai T, Endo M, Clouse ME.
    Transplant Proc; 1994 Aug; 26(4):2391. PubMed ID: 8066784
    [No Abstract] [Full Text] [Related]

  • 36. Accelerated rejection of a skin graft after liver transplantation from a sensitized donor: functional aspects of microchimerism.
    Dahmen U, Tanigawa T, Rogiers X, Lindkaer-Jensen S, Broelsch CE.
    Transplant Proc; 1996 Dec; 28(6):3243-5. PubMed ID: 8962256
    [No Abstract] [Full Text] [Related]

  • 37. Damage and repair of DNA after liver transplantation assessed by urinary thymine glycol output.
    Ichikawa N, Watanabe K, Tomikawa S, Nagao T, Uchida H.
    Transplant Proc; 1996 Jun; 28(3):1765-6. PubMed ID: 8658873
    [No Abstract] [Full Text] [Related]

  • 38. Survival of adult hepatocytes and fetal hepatic tissue transplanted into the spleens of allogeneic rats.
    Ebata H, Oikawa I, Sawa M, Kasai S, Mito M.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):998-1001. PubMed ID: 3547889
    [No Abstract] [Full Text] [Related]

  • 39. Monoclonal anti-tumor necrosis factor-alpha antibody suppresses rejection, but enhances infectious complications in rat liver allograft recipients.
    Shiraishi M, Shaked A, Yasunaga C, Hasuike Y, Imagawa DK, Busuttil RW.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):128-9. PubMed ID: 8438250
    [No Abstract] [Full Text] [Related]

  • 40. Plasma levels of hepatocyte growth factor in prolonging hepatic allografts in rats pretreated with donor-specific blood transfusion.
    Ichiguchi O, Yamaguchi Y, Miyanari N, Mori K, Hisama N, Itakura Y, Matsumoto K, Nakamura T, Ogawa M.
    Transplant Proc; 1995 Apr; 27(2):1634-6. PubMed ID: 7725432
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.